Biotech IP valuation
Consulting firms and data platforms that value biotech and pharma patent portfolios for licensing negotiations, M&A deals, litigation and capital raising.
Procurement category: consulting & market access. Bioecon selects providers and organises the work in this category to the customer's brief. Catalogue-level entry: the specific manufacturer, configuration and specification are determined at the enquiry stage. Price — on request.
| Category slug | consulting-market-access |
|---|---|
| Cluster | regulatory-legal |
| Article | biotech-ip-valuation |
| Identifier | bio.svc.biotech-ip-valuation.consulting-market-access |
Every item is a procurement category, not a named manufacturer's product. Bioecon is a single seller and holds no stock: supplier selection, configuration and specification are settled at enquiry, and the price is by quote.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.